American Journal of Ophthalmology
Volume 138, Issue 4 , Pages 547-553, October 2004

Corneal pharmacokinetics of topically applied azithromycin and clarithromycin

Ocular Inflammatory Disease Center, Jules Stein Eye Institute, and Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA

Accepted 30 April 2004. published online 20 September 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by Research to Prevent Blindness, Inc., New York, NY (G.N.H., B.J.M.), the Jules Stein Eye Institute Card Family Research Fund and Wasserman Fund (B.J.M.), the Skirball Foundation, Los Angeles, CA (G.N.H.), and the David May II Endowed Professorship (G.N.H.). Dr. Holland is a recipient of a Research to Prevent Blindness, Physician-Scientist Award.

PII: S0002-9394(04)00509-4

doi:10.1016/j.ajo.2004.04.071

American Journal of Ophthalmology
Volume 138, Issue 4 , Pages 547-553, October 2004

Article Tools

* Image Usage & Resolution